Furthermore, tumor samples treated with BA exhibited an increase in Cav-1 expression and a notable decrease in c-Myc and PDK1 levels in tumor tissues, providing evidence that a dosage of 250 mg/kg BA can effectively suppress glycolytic activity in vivo. This evidence concerns the gene PDK1 and neoplasm.